Spotlight on Pentavalent Rotavirus Vaccine (RotaTeq®) in the Prevention of Rotavirus Gastroenteritis in Europe†

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.6, 2010-12, pp. : 411-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tetravalent Human-Rhesus Reassortant Rotavirus Vaccine: A Review of its Immunogenicity, Tolerability and Protective Efficacy against Paediatric Rotavirus Gastroenteritis

By Foster R.H. Wagstaff A.J.

BioDrugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 155-178

Adis International

Access to resources Recommend Favorite

Rotavirus Vaccine: Current Status and Future Prospects

By Bernstein D.I.

BioDrugs, Vol. 14, Iss. 5, 2000-11 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†

By McCormack Paul L.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 339-343

Adis International

Access to resources Recommend Favorite

Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)†

By Dhillon Sohita

BioDrugs, Vol. 24, Iss. 5, 2010-10 ,pp. : 299-302

Adis International

Access to resources Recommend Favorite

Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)†

By McKeage Kate

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 265-269

Adis International

Access to resources Recommend Favorite